1,721,223 research outputs found
Supp._2_English_questionnaire_patient - Value discrepancies between nurses and patients: A survey study
No full textSupp._2_English_questionnaire_patient for Value discrepancies between nurses and patients: A survey study by Liesbeth Van Humbeeck, Simon Malfait, Els Holvoet, Dirk Vogelaers, Michel De Pauw, Nele Van Den Noortgate and Wim Van Biesen in Nursing Ethics</p
Supp._4_English_questionnaire_healthcareprovider - Value discrepancies between nurses and patients: A survey study
No full textSupp._4_English_questionnaire_healthcareprovider for Value discrepancies between nurses and patients: A survey study by Liesbeth Van Humbeeck, Simon Malfait, Els Holvoet, Dirk Vogelaers, Michel De Pauw, Nele Van Den Noortgate and Wim Van Biesen in Nursing Ethics</p
Supp._1_Dutch_questionnaire_patient - Value discrepancies between nurses and patients: A survey study
No full textSupp._1_Dutch_questionnaire_patient for Value discrepancies between nurses and patients: A survey study by Liesbeth Van Humbeeck, Simon Malfait, Els Holvoet, Dirk Vogelaers, Michel De Pauw, Nele Van Den Noortgate and Wim Van Biesen in Nursing Ethics</p
Supp._3_Dutch_questionnaire_healthcareprovider - Value discrepancies between nurses and patients: A survey study
No full textSupp._3_Dutch_questionnaire_healthcareprovider for Value discrepancies between nurses and patients: A survey study by Liesbeth Van Humbeeck, Simon Malfait, Els Holvoet, Dirk Vogelaers, Michel De Pauw, Nele Van Den Noortgate and Wim Van Biesen in Nursing Ethics</p
Supplemental Material, sj-docx-1-ptd-10.1177_08968608211034988 - Barriers and opportunities to increase PD incidence and prevalence: Lessons from a European Survey
No full textSupplemental Material, sj-docx-1-ptd-10.1177_08968608211034988 for Barriers and opportunities to increase PD incidence and prevalence: Lessons from a European Survey by Ulrika Hahn Lundström, Alferso C Abrahams, Jennifer Allen, Karmela Altabas, Clémence Béchade, Felix Burkhalter, Anne-Lorraine Clause, Richard W Corbett, Gabriele Eden, Karlien François, Louis de Laforcade, Mark Lambie, Heike Martin, Jernej Pajek, Vincenzo Panuccio, Silvia Ros-Ruiz, Dominik Steubl, Almudena Vega, Ewa Wojtaszek, Ariane Zaloszyc, Simon J Davies, Wim Van Biesen and Helga Gudmundsdottir in Peritoneal Dialysis International</p
Supplemental Material, PTD880101_supp_mat - “Can I go to Glasgow?” Learnings from patient involvement at the 17th Congress of the International Society for Peritoneal Dialysis (ISPD)
No full textSupplemental Material, PTD880101_supp_mat for “Can I go to Glasgow?” Learnings from patient involvement at the 17th Congress of the International Society for Peritoneal Dialysis (ISPD) by Talia Gutman, Karine E Manera, Amanda Baumgart, David W Johnson, Martin Wilkie, Neil Boudville, Jonathan C Craig, Jie Dong, Shilpa Jesudason, Rajnish Mehrotra, Alicia Neu, Jenny I Shen, Wim Van Biesen, Peter G Blake, Gillian Brunier, Yeoungjee Cho, Nichole Jefferson, Ilan Lenga, Neelem Mann, Asher A Mendelson, Jeffrey Perl, Rafael Mauricio Sanabria, Nicole Scholes-Roberston, Daniel Schwartz, Isaac Teitelbaum and Allison Tong in Peritoneal Dialysis International</p
Supplemental Material, sj-docx-1-ptd-10.1177_08968608211049882 - Assisted peritoneal dialysis across Europe: Practice variation and factors associated with availability
No full textSupplemental Material, sj-docx-1-ptd-10.1177_08968608211049882 for Assisted peritoneal dialysis across Europe: Practice variation and factors associated with availability by Anita van Eck van der Sluijs, Brigit C van Jaarsveld, Jennifer Allen, Karmela Altabas, Clémence Béchade, Anna A Bonenkamp, Felix Burkhalter, Anne-Lorraine Clause, Richard W Corbett, Friedo W Dekker, Gabriele Eden, Karlien François, Helga Gudmundsdottir, Ulrika Hahn Lundström, Louis de Laforcade, Mark Lambie, Heike Martin, Jernej Pajek, Vincenzo Panuccio, Silvia Ros-Ruiz, Dominik Steubl, Almudena Vega, Ewa Wojtaszek, Simon J Davies, Wim Van Biesen and Alferso C Abrahams in Peritoneal Dialysis International</p
European Society of Endocrinology clinical guideline: treatment of chronic hypoparathyroidism in adults
No full textHypoparathyroidism (HypoPT) is a rare (orphan) endocrine disease with low calcium and inappropriately low (insufficient) circulating parathyroid hormone levels, most often in adults secondary to thyroid surgery. Standard treatment is activated vitamin D analogues and calcium supplementation and not replacement of the lacking hormone, as in other hormonal deficiency states. The purpose of this guideline is to provide clinicians with guidance on the treatment and monitoring of chronic HypoPT in adults who do not have end-stage renal disease. We intend to draft a practical guideline, focusing on operationalized recommendations deemed to be useful in the daily management of patients. This guideline was developed and solely sponsored by The European Society of Endocrinology, supported by CBO (Dutch Institute for Health Care Improvement) and based on the Grading of Recommendations Assessment, Development and Evaluation (GRADE) principles as a methodological base. The clinical question on which the systematic literature search was based and for which available evidence was synthesized was: what is the best treatment for adult patients with chronic HypoPT? This systematic search found 1100 articles, which was reduced to 312 based on title and abstract. The working group assessed these for eligibility in more detail, and 32 full-text articles were assessed. For the final recommendations, other literature was also taken into account. Little evidence is available on how best to treat HypoPT. Data on quality of life and the risk of complications have just started to emerge, and clinical trials on how to optimize therapy are essentially non-existent. Most studies are of limited sample size, hampering firm conclusions. No studies are available relating target calcium levels with clinically relevant endpoints. Hence it is not possible to formulate recommendations based on strict evidence. This guideline is therefore mainly based on how patients are managed in clinical practice, as reported in small case series and based on the experiences of the authors
Going Beyond Counting First Authors in Author Co-citation Analysis
Get PDFThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
- …
